Trilipix and Mobility decreased - a phase IV clinical study of FDA data

Summary:

Mobility decreased is reported as a side effect among people who take Trilipix (choline fenofibrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Plavix, and have High blood pressure.

The phase IV clinical study analyzes which people have Mobility decreased when taking Trilipix. It is created by eHealthMe based on reports of 5,551 people who have side effects when taking Trilipix from the FDA, and is updated regularly.

What is Trilipix?

Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,774 drugs and 1,632 conditions by eHealthMe. Check the latest studies of Mobility decreased.

On Jul, 19, 2026

5,551 people reported to have side effects when taking Trilipix.
Among them, 21 people (0.38%) have Mobility decreased.

Could Trilipix cause Mobility decreased?

Among these 21 people:

How long have people been on Trilipix when they have Mobility decreased? *

What is the gender of people who have Mobility decreased when taking Trilipix? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Mobility decreased when taking Trilipix? *

What are other drugs people take besides Trilipix? *

Aspirin: 5 people, 23.81%
Plavix: 5 people, 23.81%
Metformin: 4 people, 19.05%
Gabapentin: 4 people, 19.05%
Crestor: 3 people, 14.29%
Atenolol And Chlorthalidone: 3 people, 14.29%
Oxycodone: 3 people, 14.29%
Allegra: 3 people, 14.29%
Cymbalta: 3 people, 14.29%
Lisinopril: 2 people, 9.52%

What are other side effects people have besides Mobility decreased? *

Pain: 9 people, 42.86%
Pain In Extremity: 5 people, 23.81%
Stress And Anxiety: 4 people, 19.05%
Fatigue (feeling of tiredness): 4 people, 19.05%
Muscle Aches (muscle pain): 4 people, 19.05%
Personality Change: 4 people, 19.05%
Back Pain: 4 people, 19.05%
Blood Glucose Increased: 4 people, 19.05%
High Blood Pressure: 4 people, 19.05%
Neuralgia (pain in one or more nerves): 3 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 19.05%
Depression: 3 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
Hiv Infection: 2 people, 9.52%
Diabetes: 2 people, 9.52%
Stress And Anxiety: 1 person, 4.76%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 4.76%
High Density Lipoprotein Decreased: 1 person, 4.76%
Insomnia (sleeplessness): 1 person, 4.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Trilipix and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trilipix:

Trilipix (5,915 reports)

Browse all side effects of Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mobility decreased:

Mobility decreased (1,774 drugs)

Browse all the conditions that are associated with Mobility decreased:

Mobility decreased (1,632 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on choline fenofibrate (the active ingredients of Trilipix) and Trilipix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.